Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS111 in Advanced or Metastatic Non-small Cell Lung Cancer
NCT04993391Phase 2Terminated
- Sponsor
- Suzhou Junjing BioSciences
- Start
- Jul 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of js111 in non-small cell lung cancer (NSCLC), sponsored by Suzhou Junjing BioSciences. Started Jul 2021; status: terminated.
02
Drugs
js111
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04993391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04993391.